| Target Price | £4.90 |
| Price | £3.19 |
| Potential |
53.34%
register free of charge
|
| Number of Estimates | 25 |
|
25 Analysts have issued a price target Rentokil Initial 2027 .
The average Rentokil Initial target price is £4.90.
This is
53.34%
register free of charge
£6.62
107.17%
register free of charge
£3.03
5.10%
register free of charge
|
|
| A rating was issued by 31 analysts: 20 Analysts recommend Rentokil Initial to buy, 8 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rentokil Initial stock has an average upside potential 2027 of
53.34%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion £ | 6.91 | 7.59 |
| 4.40% | 9.90% | |
| EBITDA Margin | 14.90% | 21.42% |
| 12.85% | 43.80% | |
| Net Margin | 6.80% | 9.86% |
| 14.85% | 44.92% |
23 Analysts have issued a sales forecast Rentokil Initial 2026 . The average Rentokil Initial sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Rentokil Initial EBITDA forecast 2026. The average Rentokil Initial EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
25 Rentokil Initial Analysts have issued a net profit forecast 2026. The average Rentokil Initial net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share £ | 0.18 | 0.30 |
| 28.57% | 66.67% | |
| P/E | 10.77 | |
| EV/Sales | 1.55 |
25 Analysts have issued a Rentokil Initial forecast for earnings per share. The average Rentokil Initial EPS is
This results in the following potential growth metrics and future valuations:
Rentokil Initial...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| RBC Capital Markets |
Locked
➜
Locked
|
Locked | Jun 05 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Mar 10 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 05 2026 |
| Berenberg Bank |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
RBC Capital Markets:
Locked
➜
Locked
|
Jun 05 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 16 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Mar 10 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 05 2026 |
|
Locked
Berenberg Bank:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


